Treatment of Idiopathic Pulmonary Fibrosis by Inhaled Silybin Dry Powder Prepared via the Nanosuspension Spray Drying Technology

Abstract

Idiopathic pulmonary fibrosis (IPF) is a kind of lifethreatening interstitial lung disease characterized by progressive dyspnea with accurate pathogenesis unknown. At present, heat shock protein inhibitors are gradually used to treat IPF. Silybin, a heat shock protein C-terminal inhibitor, has high safety and good application prospects. In this work, we have developed a silybin powder able to be used for inhalation administration for the treatment of IPF. Silybin powder was prepared by the spray drying method and identified using cascade impactometry, particle size, scanning electron microscopy (SEM), differential scanning calorimetry (DSC), X-ray diffraction (XRD), and Fourier transform infrared (FT-IR) spectroscopy. A rat model of bleomycininduced IPF was used to assess the effect of inhaled silybin spray-dried powder. Lung hydroxyproline content, wet weight, histology, inflammatory factor expression, and gene expression were examined. The results showed that inhaled silybin spray-dried powder alleviated inflammation and fibrosis, limited hydroxyproline accumulation in the lungs, modulated gene expression in the development of IPF, and improved postoperative survival. The results of this study suggest that silybin spray-dried powder is an attractive candidate for the treatment of IPF.

Silibinin Targeting Heat Shock Protein 90 Represents a Novel Approach to Alleviate Nonalcoholic Fatty Liver Disease by Simultaneously Lowering Hepatic Lipotoxicity and Enhancing Gut Barrier Function

“…Silibinin (Sil) with a purity of ≥98% was laboratory made, which showed silibinin A and silibinin B in a molar ratio of 1:1. Asiatic acid with a purity of ≥99% was purchased from MCE company (New Jersey, USA) . Kits for hematoxylin and eosin stain (H&E), Oil Red O, periodic acid-schiff (PAS), interleukin-6 (IL-6), interleukin −1 β (IL-1 β ), and tumor necrosis factor- α (TNF- α ) were provided by Servicebio Biotechnology (Wuhan, China).…”

Liposome-Based Silibinin for Mitigating Nonalcoholic Fatty Liver Disease: Dual Effects via Parenteral and Intestinal Routes

“…Sil was laboratory homemade (purity ≥98%), which had been identified in our previous study . Res, Cou, psoralen (Pso), and cholic acid (purity ≥98%) were bought from Aladdin Biochemical Technology (Shanghai, China).…”

Nanosuspension-Based Drug Delivery Systems for Topical Applications

“…17,73 In contrast, the pulmonary route has gained increasing attention as a potential method for systemic drug delivery due to the extensive alveolar surface area, the delicate epithelial barrier, and the significant vascularization conducive to drug absorption. [75][76][77][78] Furthermore, drugs administered via the pulmonary route bypass the first-pass metabolism of the gastrointestinal tract, enter the systemic circulation, and may eliminate barriers associated with patient compliance. 5,19,79 However, the effectiveness of drug delivery through this route depends significantly on factors such as aerosol particle size, particle shape and geometry, surface adhesive properties, and the mechanism and rate of removal from the respiratory system.…”